...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Sleep

With ZCC don't we just go to sleep for 3 or 4 years unless Don erodes our equity further?

At least at RVX we have ORI watching guard.    :)

GLTA

Toinv

Share
New Message
Please login to post a reply